Third quarter earnings before interest, tax, depreciation and amortization (EBITDA) for DSM rose 13% to €323m ($359m), and sales jumped 3% to around €2bn.
The markets are reacting positively to DSM’s third quarter 2015 results as they show the underlying business, particularly nutrition, is performing well, says an analyst.
Spot prices for vitamin E bottomed out in H1 2015, said Dutch nutrition giant, DSM, in releasing its Q2 results today with it claiming Chinese competitors in the space are weakened.
A new thermostable enzyme, arising from the DSM and Novozymes partnership, is said to improve the quality of feed through enhancing the digestibility of a wide range of cereals.
DSM is expecting further growth in meat production this year, an opportunity for its animal nutrition segment that showed flat organic growth in 2013 following weak demand, disease outbreaks and price pressure on vitamin E.